Technical / White Paper

First Low Dose Resistant Starch (RS2)

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This Technical / White Paper has been written by Solnul™ , and any views and opinions expressed do not necessarily reflect those of

First Low Dose Resistant Starch (RS2)

Clinically-proven at doses as low as 3.5 g, Solnul™ is the first low dose resistant starch, effective at 1/10 of the previously documented dosage.

Get the insider story and learn about:

  • Top digestive health complaints and opportunity for OTC prebiotic supplements
  • The clinical effects of 3.5 g and 7 g of prebiotic resistant starch (RS2)
  • Bifidobacterium increases​ and supplementation durations
  • Why resistant starch is the real gold
  • How a multi-functional ingredient meets the demand for IBS products
  • What substantiated claims can be achieved at low doses of Solnul™ (Resistant Potato Starch)

Latest content from Solnul™

Supplier info centre